DOCSLIB.ORG

Mouse Gipc1 Conditional Knockout Project (CRISPR/Cas9)

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Mouse Gipc1 Conditional Knockout Project (CRISPR/Cas9) https://www.alphaknockout.com Mouse Gipc1 Conditional Knockout Project (CRISPR/Cas9) Objective: To create a Gipc1 conditional knockout Mouse model (C57BL/6J) by CRISPR/Cas-mediated genome engineering. Strategy summary: The Gipc1 gene (NCBI Reference Sequence: NM_018771 ; Ensembl: ENSMUSG00000019433 ) is located on Mouse chromosome 8. 7 exons are identified, with the ATG start codon in exon 2 and the TAA stop codon in exon 7 (Transcript: ENSMUST00000019577). Exon 2 will be selected as conditional knockout region (cKO region). Deletion of this region should result in the loss of function of the Mouse Gipc1 gene. To engineer the targeting vector, homologous arms and cKO region will be generated by PCR using BAC clone RP23-455G23 as template. Cas9, gRNA and targeting vector will be co-injected into fertilized eggs for cKO Mouse production. The pups will be genotyped by PCR followed by sequencing analysis. Note: Mice homozygous for a gene trapped allele display reduced body and heart weight, selective arteriogenesis and arterial endothelial cell defects, and impaired cardiac performance and wound healing. Mice homozygous for a knock-out allele exhibit low molecular weight proteinuria. Exon 2 starts from about 100% of the coding region. The knockout of Exon 2 will result in frameshift of the gene. The size of intron 1 for 5'-loxP site insertion: 8221 bp, and the size of intron 2 for 3'-loxP site insertion: 674 bp. The size of effective cKO region: ~788 bp. The cKO region does not have any other known gene. Page 1 of 8 https://www.alphaknockout.com Overview of the Targeting Strategy Wildtype allele gRNA region 5' gRNA region 3' 1 2 3 4 5 7 Targeting vector Targeted allele Constitutive KO allele (After Cre recombination) Legends Exon of mouse Gipc1 Homology arm cKO region loxP site Page 2 of 8 https://www.alphaknockout.com Overview of the Dot Plot Window size: 10 bp Forward Reverse Complement Sequence 12 Note: The sequence of homologous arms and cKO region is aligned with itself to determine if there are tandem repeats. No significant tandem repeat is found in the dot plot matrix. So this region is suitable for PCR screening or sequencing analysis. Overview of the GC Content Distribution Window size: 300 bp Sequence 12 Summary: Full Length(7288bp) | A(23.23% 1693) | C(26.19% 1909) | T(23.41% 1706) | G(27.17% 1980) Note: The sequence of homologous arms and cKO region is analyzed to determine the GC content. Significant high GC-content regions are found. It may be difficult to construct this targeting vector. Page 3 of 8 https://www.alphaknockout.com BLAT Search Results (up) QUERY SCORE START END QSIZE IDENTITY CHROM STRAND START END SPAN -------------------------------------------------------------------------------------------------------------- browser details YourSeq 3000 1 3000 3000 100.0% chr8 + 83657744 83660743 3000 browser details YourSeq 160 1922 2181 3000 96.0% chrX - 160432846 160433146 301 browser details YourSeq 158 1796 2077 3000 94.9% chr19 + 43685045 43685491 447 browser details YourSeq 153 1914 2091 3000 94.8% chr9 - 14405665 14405846 182 browser details YourSeq 153 1936 2178 3000 95.4% chr1 - 63106719 63107316 598 browser details YourSeq 150 1822 2073 3000 89.7% chr10 + 88354129 88354361 233 browser details YourSeq 148 1922 2077 3000 97.5% chr4 + 98918636 98918791 156 browser details YourSeq 148 1796 2069 3000 94.6% chr15 + 28200549 28200847 299 browser details YourSeq 147 1914 2077 3000 95.7% chr3 - 119975257 119975424 168 browser details YourSeq 147 1914 2077 3000 95.7% chr1 - 20686926 20687095 170 browser details YourSeq 146 1914 2077 3000 95.0% chr9 - 115289921 115290083 163 browser details YourSeq 146 1540 2077 3000 82.3% chr6 - 120354979 120355162 184 browser details YourSeq 146 1912 2077 3000 94.6% chr4 - 136085300 136085470 171 browser details YourSeq 146 1796 2259 3000 82.7% chr12 + 111566336 111566618 283 browser details YourSeq 145 1922 2077 3000 96.8% chr4 + 92883209 92883366 158 browser details YourSeq 144 1922 2079 3000 94.3% chr15 - 43896422 43896578 157 browser details YourSeq 144 1922 2089 3000 94.0% chr15 - 39085597 39085776 180 browser details YourSeq 144 1615 2074 3000 84.9% chr12 + 24813471 24813629 159 browser details YourSeq 143 1914 2077 3000 93.2% chr19 + 29214709 29214871 163 browser details YourSeq 142 1923 2077 3000 96.2% chr6 - 143021051 143021209 159 Note: The 3000 bp section upstream of Exon 2 is BLAT searched against the genome. No significant similarity is found. BLAT Search Results (down) QUERY SCORE START END QSIZE IDENTITY CHROM STRAND START END SPAN ----------------------------------------------------------------------------------------------- browser details YourSeq 3000 1 3000 3000 100.0% chr8 + 83661532 83664531 3000 browser details YourSeq 65 430 516 3000 87.4% chr10 - 81341584 81341670 87 browser details YourSeq 60 2046 2154 3000 82.5% chr10 + 126870446 126870551 106 browser details YourSeq 57 2078 2205 3000 90.0% chr10 + 84607955 84608084 130 browser details YourSeq 52 2092 2190 3000 92.0% chr14 + 20761984 20969836 207853 browser details YourSeq 49 2042 2124 3000 82.7% chr7 + 19346978 19347401 424 browser details YourSeq 48 2122 2189 3000 91.4% chr7 + 133592100 133592169 70 browser details YourSeq 48 2046 2226 3000 90.2% chr5 + 37636910 37637101 192 browser details YourSeq 46 2045 2114 3000 82.9% chr12 - 82540402 82540471 70 browser details YourSeq 46 2090 2165 3000 87.8% chr10 + 103449631 103449705 75 browser details YourSeq 44 2039 2100 3000 85.5% chr12 - 69498473 69498534 62 browser details YourSeq 43 2046 2246 3000 93.9% chr5 - 111685174 111685392 219 browser details YourSeq 43 2039 2189 3000 75.3% chr1 + 23756415 23756566 152 browser details YourSeq 42 2050 2185 3000 93.8% chr12 - 19457600 19457738 139 browser details YourSeq 42 2046 2176 3000 93.8% chr16 + 25214745 25214877 133 browser details YourSeq 41 2038 2204 3000 75.0% chr11 - 20209868 20210024 157 browser details YourSeq 41 2052 2203 3000 95.6% chr10 - 29647672 29648252 581 browser details YourSeq 41 2050 2185 3000 93.7% chr12 + 21816915 21817055 141 browser details YourSeq 40 2090 2154 3000 93.5% chrX - 12931471 12931536 66 browser details YourSeq 40 2048 2337 3000 55.3% chr17 + 26232921 26233033 113 Note: The 3000 bp section downstream of Exon 2 is BLAT searched against the genome. No significant similarity is found. Page 4 of 8 https://www.alphaknockout.com Gene and protein information: Gipc1 GIPC PDZ domain containing family, member 1 [ Mus musculus (house mouse) ] Gene ID: 67903, updated on 10-Oct-2019 Gene summary Official Symbol Gipc1 provided by MGI Official Full Name GIPC PDZ domain containing family, member 1 provided by MGI Primary source MGI:MGI:1926252 See related Ensembl:ENSMUSG00000019433 Gene type protein coding RefSeq status VALIDATED Organism Mus musculus Lineage Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae; Murinae; Mus; Mus Also known as GIPC; TIP-2; TaxIP2; Semcap1; Glut1CIP; Rgs19ip1 Expression Ubiquitous expression in stomach adult (RPKM 41.0), colon adult (RPKM 40.6) and 28 other tissues See more Orthologs human all Genomic context Location: 8; 8 C2 See Gipc1 in Genome Data Viewer Exon count: 8 Annotation release Status Assembly Chr Location 108 current GRCm38.p6 (GCF_000001635.26) 8 NC_000074.6 (83649408..83664789) Build 37.2 previous assembly MGSCv37 (GCF_000001635.18) 8 NC_000074.5 (86176577..86188688) Chromosome 8 - NC_000074.6 Page 5 of 8 https://www.alphaknockout.com Transcript information: This gene has 3 transcripts Gene: Gipc1 ENSMUSG00000019433 Description GIPC PDZ domain containing family, member 1 [Source:MGI Symbol;Acc:MGI:1926252] Gene Synonyms Glut1CIP, Rgs19ip1, Semcap1, TIP-2, TaxIP2, neurophilin1-IP, synectin Location Chromosome 8: 83,652,677-83,664,694 forward strand. GRCm38:CM001001.2 About this gene This gene has 3 transcripts (splice variants), 176 orthologues, 2 paralogues, is a member of 1 Ensembl protein family and is associated with 12 phenotypes. Transcripts Name Transcript ID bp Protein Translation ID Biotype CCDS UniProt Flags Gipc1-201 ENSMUST00000019577.9 1522 333aa ENSMUSP00000019577.8 Protein coding CCDS22457 Q9Z0G0 TSL:1 GENCODE basic APPRIS P1 Gipc1-203 ENSMUST00000212463.1 476 65aa ENSMUSP00000148824.1 Protein coding - A0A1D5RML2 CDS 3' incomplete TSL:5 Gipc1-202 ENSMUST00000211985.1 370 105aa ENSMUSP00000148847.1 Protein coding - A0A1D5RMN2 CDS 3' incomplete TSL:3 Page 6 of 8 https://www.alphaknockout.com 32.02 kb Forward strand 83.65Mb 83.66Mb 83.67Mb Genes (Comprehensive set... Gipc1-201 >protein coding Ptger1-201 >protein coding Gipc1-202 >protein coding Ptger1-202 >retained intron Gipc1-203 >protein coding Ptger1-203 >lncRNA Contigs < AC151992.3 < AC164432.3 Genes < Pkn1-201protein coding (Comprehensive set... < Pkn1-204nonsense mediated decay < Pkn1-208protein coding < Pkn1-203retained intron < Pkn1-202retained intron < Pkn1-207lncRNA < Pkn1-209lncRNA Regulatory Build 83.65Mb 83.66Mb 83.67Mb Reverse strand 32.02 kb Regulation Legend CTCF Enhancer Open Chromatin Promoter Promoter Flank Gene Legend Protein Coding Ensembl protein coding merged Ensembl/Havana Non-Protein Coding RNA gene processed transcript Page 7 of 8 https://www.alphaknockout.com Transcript: ENSMUST00000019577 12.02 kb Forward strand Gipc1-201 >protein coding ENSMUSP00000019... PDB-ENSP mappings MobiDB lite Low complexity (Seg) Superfamily PDZ superfamily SMART PDZ domain Pfam PDZ domain PROSITE profiles PDZ domain PIRSF PDZ domain-containing protein GIPC1/2/3 PANTHER PTHR12259:SF4 PDZ domain-containing protein GIPC1/2/3 Gene3D 2.30.42.10 CDD cd00992 All sequence SNPs/i... Sequence variants (dbSNP and all other sources) Variant Legend missense variant synonymous variant Scale bar 0 40 80 120 160 200 240 280 333 We wish to acknowledge the following valuable scientific information resources: Ensembl, MGI, NCBI, UCSC. Page 8 of 8.
Load more

Recommended publications
  • Supplementary Figures 1-14 and Supplementary References
    SUPPORTING INFORMATION Spatial Cross-Talk Between Oxidative Stress and DNA Replication in Human Fibroblasts Marko Radulovic,1,2 Noor O Baqader,1 Kai Stoeber,3† and Jasminka Godovac-Zimmermann1* 1Division of Medicine, University College London, Center for Nephrology, Royal Free Campus, Rowland Hill Street, London, NW3 2PF, UK. 2Insitute of Oncology and Radiology, Pasterova 14, 11000 Belgrade, Serbia 3Research Department of Pathology and UCL Cancer Institute, Rockefeller Building, University College London, University Street, London WC1E 6JJ, UK †Present Address: Shionogi Europe, 33 Kingsway, Holborn, London WC2B 6UF, UK TABLE OF CONTENTS 1. Supplementary Figures 1-14 and Supplementary References. Figure S-1. Network and joint spatial razor plot for 18 enzymes of glycolysis and the pentose phosphate shunt. Figure S-2. Correlation of SILAC ratios between OXS and OAC for proteins assigned to the SAME class. Figure S-3. Overlap matrix (r = 1) for groups of CORUM complexes containing 19 proteins of the 49-set. Figure S-4. Joint spatial razor plots for the Nop56p complex and FIB-associated complex involved in ribosome biogenesis. Figure S-5. Analysis of the response of emerin nuclear envelope complexes to OXS and OAC. Figure S-6. Joint spatial razor plots for the CCT protein folding complex, ATP synthase and V-Type ATPase. Figure S-7. Joint spatial razor plots showing changes in subcellular abundance and compartmental distribution for proteins annotated by GO to nucleocytoplasmic transport (GO:0006913). Figure S-8. Joint spatial razor plots showing changes in subcellular abundance and compartmental distribution for proteins annotated to endocytosis (GO:0006897). Figure S-9. Joint spatial razor plots for 401-set proteins annotated by GO to small GTPase mediated signal transduction (GO:0007264) and/or GTPase activity (GO:0003924).
    [Show full text]
  • APPL1 Associates with Trka and GIPC1 and Is Required for Nerve Growth Factor-Mediated Signal Transduction
    University of Montana ScholarWorks at University of Montana Biomedical and Pharmaceutical Sciences Faculty Publications Biomedical and Pharmaceutical Sciences 12-2006 APPL1 Associates with TrkA and GIPC1 and is Required for Nerve Growth Factor-Mediated Signal Transduction D. C. Lin C. Quevedo N. E. Brewer A. Bell J. R. Testa See next page for additional authors Follow this and additional works at: https://scholarworks.umt.edu/biopharm_pubs Part of the Medical Sciences Commons, and the Pharmacy and Pharmaceutical Sciences Commons Let us know how access to this document benefits ou.y Recommended Citation Lin, D. C.; Quevedo, C.; Brewer, N. E.; Bell, A.; Testa, J. R.; Grimes, Mark L.; Miller, F. D.; and Kaplan, D. R., "APPL1 Associates with TrkA and GIPC1 and is Required for Nerve Growth Factor-Mediated Signal Transduction" (2006). Biomedical and Pharmaceutical Sciences Faculty Publications. 13. https://scholarworks.umt.edu/biopharm_pubs/13 This Article is brought to you for free and open access by the Biomedical and Pharmaceutical Sciences at ScholarWorks at University of Montana. It has been accepted for inclusion in Biomedical and Pharmaceutical Sciences Faculty Publications by an authorized administrator of ScholarWorks at University of Montana. For more information, please contact [email protected]. Authors D. C. Lin, C. Quevedo, N. E. Brewer, A. Bell, J. R. Testa, Mark L. Grimes, F. D. Miller, and D. R. Kaplan This article is available at ScholarWorks at University of Montana: https://scholarworks.umt.edu/biopharm_pubs/13 MOLECULAR AND CELLULAR BIOLOGY, Dec. 2006, p. 8928–8941 Vol. 26, No. 23 0270-7306/06/$08.00ϩ0 doi:10.1128/MCB.00228-06 Copyright © 2006, American Society for Microbiology.
    [Show full text]
  • Table S1. Identified Proteins with Exclusive Expression in Cerebellum of Rats of Control, 10Mg F/L and 50Mg F/L Groups
    Table S1. Identified proteins with exclusive expression in cerebellum of rats of control, 10mg F/L and 50mg F/L groups. Accession PLGS Protein Name Group IDa Score Q3TXS7 26S proteasome non-ATPase regulatory subunit 1 435 Control Q9CQX8 28S ribosomal protein S36_ mitochondrial 197 Control P52760 2-iminobutanoate/2-iminopropanoate deaminase 315 Control Q60597 2-oxoglutarate dehydrogenase_ mitochondrial 67 Control P24815 3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1 84 Control Q99L13 3-hydroxyisobutyrate dehydrogenase_ mitochondrial 114 Control P61922 4-aminobutyrate aminotransferase_ mitochondrial 470 Control P10852 4F2 cell-surface antigen heavy chain 220 Control Q8K010 5-oxoprolinase 197 Control P47955 60S acidic ribosomal protein P1 190 Control P70266 6-phosphofructo-2-kinase/fructose-2_6-bisphosphatase 1 113 Control Q8QZT1 Acetyl-CoA acetyltransferase_ mitochondrial 402 Control Q9R0Y5 Adenylate kinase isoenzyme 1 623 Control Q80TS3 Adhesion G protein-coupled receptor L3 59 Control B7ZCC9 Adhesion G-protein coupled receptor G4 139 Control Q6P5E6 ADP-ribosylation factor-binding protein GGA2 45 Control E9Q394 A-kinase anchor protein 13 60 Control Q80Y20 Alkylated DNA repair protein alkB homolog 8 111 Control P07758 Alpha-1-antitrypsin 1-1 78 Control P22599 Alpha-1-antitrypsin 1-2 78 Control Q00896 Alpha-1-antitrypsin 1-3 78 Control Q00897 Alpha-1-antitrypsin 1-4 78 Control P57780 Alpha-actinin-4 58 Control Q9QYC0 Alpha-adducin 270 Control Q9DB05 Alpha-soluble NSF attachment protein 156 Control Q6PAM1 Alpha-taxilin 161
    [Show full text]
  • Confirmation of Pathogenic Mechanisms by SARS-Cov-2–Host
    Messina et al. Cell Death and Disease (2021) 12:788 https://doi.org/10.1038/s41419-021-03881-8 Cell Death & Disease ARTICLE Open Access Looking for pathways related to COVID-19: confirmation of pathogenic mechanisms by SARS-CoV-2–host interactome Francesco Messina 1, Emanuela Giombini1, Chiara Montaldo1, Ashish Arunkumar Sharma2, Antonio Zoccoli3, Rafick-Pierre Sekaly2, Franco Locatelli4, Alimuddin Zumla5, Markus Maeurer6,7, Maria R. Capobianchi1, Francesco Nicola Lauria1 and Giuseppe Ippolito 1 Abstract In the last months, many studies have clearly described several mechanisms of SARS-CoV-2 infection at cell and tissue level, but the mechanisms of interaction between host and SARS-CoV-2, determining the grade of COVID-19 severity, are still unknown. We provide a network analysis on protein–protein interactions (PPI) between viral and host proteins to better identify host biological responses, induced by both whole proteome of SARS-CoV-2 and specific viral proteins. A host-virus interactome was inferred, applying an explorative algorithm (Random Walk with Restart, RWR) triggered by 28 proteins of SARS-CoV-2. The analysis of PPI allowed to estimate the distribution of SARS-CoV-2 proteins in the host cell. Interactome built around one single viral protein allowed to define a different response, underlining as ORF8 and ORF3a modulated cardiovascular diseases and pro-inflammatory pathways, respectively. Finally, the network-based approach highlighted a possible direct action of ORF3a and NS7b to enhancing Bradykinin Storm. This network-based representation of SARS-CoV-2 infection could be a framework for pathogenic evaluation of specific 1234567890():,; 1234567890():,; 1234567890():,; 1234567890():,; clinical outcomes.
    [Show full text]
  • And Pancreatic Cancer: from the Role of Evs to the Interference with EV-Mediated Reciprocal Communication
    biomedicines Review Extracellular Vesicles (EVs) and Pancreatic Cancer: From the Role of EVs to the Interference with EV-Mediated Reciprocal Communication 1, 1, 1 1 1 Sokviseth Moeng y, Seung Wan Son y, Jong Sun Lee , Han Yeoung Lee , Tae Hee Kim , Soo Young Choi 1, Hyo Jeong Kuh 2 and Jong Kook Park 1,* 1 Department of Biomedical Science and Research Institute for Bioscience & Biotechnology, Hallym University, Chunchon 24252, Korea; [email protected] (S.M.); [email protected] (S.W.S.); [email protected] (J.S.L.); [email protected] (H.Y.L.); [email protected] (T.H.K.); [email protected] (S.Y.C.) 2 Department of Medical Life Sciences, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea; [email protected] * Correspondence: [email protected]; Tel.: +82-33-248-2114 These authors contributed equally. y Received: 29 June 2020; Accepted: 1 August 2020; Published: 3 August 2020 Abstract: Pancreatic cancer is malignant and the seventh leading cause of cancer-related deaths worldwide. However, chemotherapy and radiotherapy are—at most—moderately effective, indicating the need for new and different kinds of therapies to manage this disease. It has been proposed that the biologic properties of pancreatic cancer cells are finely tuned by the dynamic microenvironment, which includes extracellular matrix, cancer-associated cells, and diverse immune cells. Accumulating evidence has demonstrated that extracellular vesicles (EVs) play an essential role in communication between heterogeneous subpopulations of cells by transmitting multiplex biomolecules. EV-mediated cell–cell communication ultimately contributes to several aspects of pancreatic cancer, such as growth, angiogenesis, metastasis and therapeutic resistance.
    [Show full text]
  • Integrin Traffic – the Update
    ß 2015. Published by The Company of Biologists Ltd | Journal of Cell Science (2015) 128, 839–852 doi:10.1242/jcs.161653 COMMENTARY Integrin traffic – the update Nicola De Franceschi*, Hellyeh Hamidi*, Jonna Alanko*, Pranshu Sahgal and Johanna Ivaska` ABSTRACT thus integrin signalling, by tightly controlling specific integrin heterodimer availability at the cell surface. With increasing interest Integrins are a family of transmembrane cell surface molecules that on the biological relevance of integrin traffic, the number of constitute the principal adhesion receptors for the extracellular matrix adaptor and signalling proteins and cellular machineries identified (ECM) and are indispensable for the existence of multicellular as key regulators of this pathway is rapidly expanding and thus organisms. In vertebrates, 24 different integrin heterodimers exist reveals the complexity of integrin traffic regulation and the close with differing substrate specificity and tissue expression. Integrin– connection with the cytoskeletal and signalling apparatus of a cell. extracellular-ligand interaction provides a physical anchor for the cell Importantly, conceptual progress in the field has identified well- and triggers a vast array of intracellular signalling events that known cancer oncogenes and mutations as being crucial regulators determine cell fate. Dynamic remodelling of adhesions, through rapid of integrin traffic and, therefore, cell invasion and metastasis. endocytic and exocytic trafficking of integrin receptors, is an Mounting data highlights how integrin trafficking is deeply wired important mechanism employed by cells to regulate integrin–ECM into the cytoskeletal and signalling apparatus of a cell and how interactions, and thus cellular signalling, during processes such as integrin trafficking is tightly and spatially regulated in the cell.
    [Show full text]
  • Gipc3 Mutations Associated with Audiogenic Seizures and Sensorineural Hearing Loss in Mouse and Human
    ARTICLE Received 18 Aug 2010 | Accepted 19 Jan 2011 | Published 15 Feb 2011 DOI: 10.1038/ncomms1200 Gipc3 mutations associated with audiogenic seizures and sensorineural hearing loss in mouse and human Nikoletta Charizopoulou1 , Andrea Lelli2 , Margit Schraders 3 , 4 , Kausik Ray 5 , Michael S. Hildebrand6 , Arabandi Ramesh 7 , C. R. Srikumari Srisailapathy7 , Jaap Oostrik 3 , 4 , Ronald J. C. Admiraal3 , Harold R. Neely 1 , Joseph R. Latoche1 , Richard J. H. Smith6 , J o h n K . N o r t h u p5 , Hannie Kremer 3 , 4 , J e f f r e y R . H o l t2 & Konrad Noben-Trauth 1 Sensorineural hearing loss affects the quality of life and communication of millions of people, but the underlying molecular mechanisms remain elusive. Here, we identify mutations in Gipc3 underlying progressive sensorineural hearing loss (age-related hearing loss 5, ahl5 ) and audiogenic seizures (juvenile audiogenic monogenic seizure 1, jams1 ) in mice and autosomal recessive deafness DFNB15 and DFNB95 in humans. Gipc3 localizes to inner ear sensory hair cells and spiral ganglion. A missense mutation in the PDZ domain has an attenuating effect on mechanotransduction and the acquisition of mature inner hair cell potassium currents. Magnitude and temporal progression of wave I amplitude of afferent neurons correlate with susceptibility and resistance to audiogenic seizures. The Gipc3 343A allele disrupts the structure of the stereocilia bundle and affects long-term function of auditory hair cells and spiral ganglion neurons. Our study suggests a pivotal role of Gipc3 in acoustic signal acquisition and propagation in cochlear hair cells. 1 Section on Neurogenetics, Laboratory of Molecular Biology, National Institute on Deafness and Other Communication Disorders, National Institutes of Health , Rockville , Maryland 20850 , USA .
    [Show full text]
  • The GIPC1‐Akt1 Pathway Is Required for the Specification of The
    EMBRYONIC STEM CELLS/INDUCED PLURIPOTENT STEM CELLS The GIPC1-Akt1 Pathway Is Required for the Specification of the Eye Field in Mouse Embryonic Stem Cells a,b a c c ANNA LA TORRE, AKINA HOSHINO, CHRISTOPHER CAVANAUGH, CAROL B. WARE, a THOMAS A. REH Key Words. Signal transduction • Retina • Retinal photoreceptors • Retinal pigmented epithelium • Neural differentiation aDepartment of Biological ABSTRACT Structure, Institute for Stem During early patterning of the neural plate, a single region of the embryonic forebrain, the eye Cells and Regenerative field, becomes competent for eye development. The hallmark of eye field specification is the Medicine and cDepartment expression of the eye field transcription factors (EFTFs). Experiments in fish, amphibians, birds, of Comparative Medicine, and mammals have demonstrated largely conserved roles for the EFTFs. Although some of the University of Washington, key signaling events that direct the synchronized expression of these factors to the eye field Seattle, Washington, USA; bDepartment of Cell Biology have been elucidated in fish and frogs, it has been more difficult to study these mechanisms and Human Anatomy, School in mammalian embryos. In this study, we have used two different methods for directed differ- of Medicine, University of entiation of mouse embryonic stem cells (mESCs) to generate eye field cells and retina in vitro California, Davis, California, to test for a role of the PDZ domain-containing protein GIPC1 in the specification of the mam- USA malian eye primordia. We find that the overexpression of a dominant-negative form of GIPC1 (dnGIPC1), as well as the downregulation of endogenous GIPC1, is sufficient to inhibit the Correspondence: Thomas A.
    [Show full text]
  • Anti-GIPC1 / NIP Antibody (ARG63385)
    Product datasheet [email protected] ARG63385 Package: 100 μg anti-GIPC1 / NIP antibody Store at: -20°C Summary Product Description Goat Polyclonal antibody recognizes GIPC1 / NIP Tested Reactivity Hu Predict Reactivity Ms, Rat, Cow Tested Application WB Specificity This antibody is expected to recognize both isoform 1 (NP_005707.1, NP_974197.1 and NP_974199.1) and isoform 2 (NP_974196.1, NP_974198.1 and NP_974223.1). Host Goat Clonality Polyclonal Isotype IgG Target Name GIPC1 / NIP Antigen Species Human Immunogen C-GAIGDAKVGRY Conjugation Un-conjugated Alternate Names GLUT1CBP; RGS-GAIP-interacting protein; RGS19IP1; C19orf3; IIP-1; Tax interaction protein 2; GIPC; Hs.6454; SYNECTIIN; GAIP C-terminus-interacting protein; Synectin; RGS19-interacting protein 1; TIP-2; NIP; PDZ domain-containing protein GIPC1; SEMCAP; SYNECTIN Application Instructions Application table Application Dilution WB 0.03 - 0.1 µg/ml Application Note WB: Recommend incubate at RT for 1h. * The dilutions indicate recommended starting dilutions and the optimal dilutions or concentrations should be determined by the scientist. Calculated Mw 36 kDa Properties Form Liquid Purification Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide. Buffer Tris saline (pH 7.3), 0.02% Sodium azide and 0.5% BSA Preservative 0.02% Sodium azide Stabilizer 0.5% BSA Concentration 0.5 mg/ml www.arigobio.com 1/2 Storage instruction For continuous use, store undiluted antibody at 2-8°C for up to a week. For long-term storage, aliquot and store at -20°C or below. Storage in frost free freezers is not recommended. Avoid repeated freeze/thaw cycles.
    [Show full text]
  • Low Incidence of GIPC3 Variants Among the Prelingual Hearing Impaired from Southern India
    Journal of Genetics (2020)99:74 Ó Indian Academy of Sciences https://doi.org/10.1007/s12041-020-01234-6 (0123456789().,-volV)(0123456789().,-volV) RESEARCH NOTE Low incidence of GIPC3 variants among the prelingual hearing impaired from southern India MURUGESAN KALAIMATHI, MAHALINGAM SUBATHRA, JUSTIN MARGRET JEFFREY , MATHIYALAGAN SELVAKUMARI, JAYASANKARAN CHANDRU , NARASIMHAN SHARANYA, VANNIYA S. PARIDHY and C. R. SRIKUMARI SRISAILAPATHY* Dr. ALM PG Institute of Basic Medical Sciences, University of Madras, Chennai 600 113, India *For correspondence. E-mail: [email protected]. Received 24 October 2019; revised 24 June 2020; accepted 24 August 2020 Abstract. The broad spectrum of causal variants in the newly discovered GIPC3 gene is well reflected in worldwide studies. Except for one missense variant, none of the reported variants had reoccurred, thus reflecting the intragenic heterogeneity. We screened all the six coding exons of GIPC3 gene in a large cohort of 177 unrelated prelingual hearing impaired after excluding the common GJB2, GJB6 nuclear and A1555G mitochondrial variants. We observed a single homozygous pathogenic frameshift variant c.685dupG (p.A229GfsX10), accounting for a low incidence (0.56%) of GIPC3 variants in south Indian population. GIPC3 being a rare gene as a causative for deafness, the allelic spectra perhaps became much more diverse from population to population, thus resulting in a minimal recurrence of the variants in our study, that were reported by authors from other parts of the globe. Keywords. prelingual deafness; c.685dupG; consanguinity; south India; GIPC3 gene. Introduction PDZ domain and flanking conserved GIPC homology (GH1 and GH2) domains (Katoh 2002). Deafness variants are recurrently identified in GJB2, In the past two decades, tremendous efforts have been SLC26A4, TMC1, OTOF and CDH23 genes (Hilgert et al.
    [Show full text]
  • Hair Cells Use Active Zones with Different Voltage Dependence Of
    Hair cells use active zones with different voltage PNAS PLUS + dependence of Ca2 influx to decompose sounds into complementary neural codes Tzu-Lun Ohna,b,c,d, Mark A. Rutherforda,e,1, Zhizi Jingb,d,f,1, Sangyong Junga,g,h,1, Carlos J. Duque-Afonsoa,b, Gerhard Hocha, Maria Magdalena Pichera,b, Anja Scharingeri,j, Nicola Strenzkeb,d,f, and Tobias Mosera,b,c,d,g,h,k,2 aInstitute for Auditory Neuroscience & InnerEarLab, University Medical Center Göttingen, 37099 Goettingen, Germany; bGöttingen Graduate School for Neurosciences and Molecular Biosciences, University of Göttingen, 37073 Goettingen, Germany; cBernstein Focus for Neurotechnology, University of Göttingen, 37073 Goettingen, Germany; dCollaborative Research Center 889, University of Göttingen, 37099 Goettingen, Germany; eDepartment of Otolaryngology, Washington University School of Medicine, St. Louis, MO 63110; fAuditory Systems Physiology Group, InnerEarLab, Department of Otolaryngology, University Medical Center Göttingen, 37099 Goettingen, Germany; gSynaptic Nanophysiology Group, Max Planck Institute for Biophysical Chemistry, 37077 Goettingen, Germany; hCenter for Nanoscale Microscopy and Molecular Physiology of the Brain, University of Göttingen, 37073 Goettingen, Germany; iInstitute of Pharmacy, Department of Pharmacology and Toxicology, University of Innsbruck, A-6020 Innsbruck, Austria; jCenter for Chemistry and Biomedicine, University of Innsbruck, A-6020 Innsbruck, Austria; and kBernstein Center for Computational Neuroscience, University of Göttingen, 37073 Goettingen, Germany Edited by A. J. Hudspeth, The Rockefeller University, New York, NY, and approved June 21, 2016 (received for review April 8, 2016) For sounds of a given frequency, spiral ganglion neurons (SGNs) with vidual IHCs (7, 11–14). IHC AZs vary in the number (11, 15) and + different thresholds and dynamic ranges collectively encode the voltage dependence of gating (11) of their Ca2 channels regardless wide range of audible sound pressures.
    [Show full text]
  • Network Mining Approach to Cancer Biomarker Discovery
    NETWORK MINING APPROACH TO CANCER BIOMARKER DISCOVERY THESIS Presented in Partial Fulfillment of the Requirements for the Degree Master of Science in the Graduate School of The Ohio State University By Praneeth Uppalapati, B.E. Graduate Program in Computer Science and Engineering The Ohio State University 2010 Thesis Committee: Dr. Kun Huang, Advisor Dr. Raghu Machiraju Copyright by Praneeth Uppalapati 2010 ABSTRACT With the rapid development of high throughput gene expression profiling technology, molecule profiling has become a powerful tool to characterize disease subtypes and discover gene signatures. Most existing gene signature discovery methods apply statistical methods to select genes whose expression values can differentiate different subject groups. However, a drawback of these approaches is that the selected genes are not functionally related and hence cannot reveal biological mechanism behind the difference in the patient groups. Gene co-expression network analysis can be used to mine functionally related sets of genes that can be marked as potential biomarkers through survival analysis. We present an efficient heuristic algorithm EigenCut that exploits the properties of gene co- expression networks to mine functionally related and dense modules of genes. We apply this method to brain tumor (Glioblastoma Multiforme) study to obtain functionally related clusters. If functional groups of genes with predictive power on patient prognosis can be identified, insights on the mechanisms related to metastasis in GBM can be obtained and better therapeutical plan can be developed. We predicted potential biomarkers by dividing the patients into two groups based on their expression profiles over the genes in the clusters and comparing their survival outcome through survival analysis.
    [Show full text]